Fig. 2From: Structural and functional brain biomarkers of clinical response to rTMS of medication-resistant auditory hallucinations in schizophrenia patients: study protocol for a randomized sham-controlled double-blind clinical trialDescription of the enrolment, treatment, and assessments during the study protocolAHRS Auditory Hallucinations Rating Scale, BDI Beck Depression Inventory, BDNF brain-derived neurotrophic factor, HCS Hallucination Change Score, MRI magnetic resonance imaging, PANSS Positive And Negative Syndrome Scale, MEP motor-evoked potentials, PSYRATS Psychotic Symptom Rating Scale, rTMS repetitive transcranial magnetic stimulation, t time point, W week.Back to article page